Medtronic (MDT) Ratings Reiterated

Medtronic, Inc. (NYSE: MDT) had ratings on them reiterated by analysts.

Collins Stewart reiterated its "Neutral" rating on Medtronic, Inc. (MDT). They have a price target of $37.00 on the company.

Goldman Sachs (NYSE:GS) reiterated its "Neutral" rating on Medtronic, Inc.

Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Medtronic, Inc. They have a price target of $43.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Neutral" rating on Medtronic, Inc.